OptimizeRx OPRX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.4M— | —— | —— | —— | $3.25M— | ||
| $4.73M— | —— | —— | —— | $4.99M— | ||
| $1.83M— | —— | —— | —— | $1.56M-47.0% | ||
| $1.06M-1.3% | $1.08M-0.2% | $1.08M+0.6% | $1.07M-1.8% | $1.09M0.0% | ||
| $19.45M— | —— | —— | —— | $24.03M— | ||
| -$495K-110% | $5.02M+544% | $779K-49.2% | $1.53M+170% | -$2.2M-2,719% | ||
| —— | $92K0.0% | $92K0.0% | $92K0.0% | $92K-95.1% | ||
| $358K+10.2% | $325K+86.8% | $174K-60.2% | $437K+151% | $174K-39.6% | ||
| —— | —— | —— | —— | —— | ||
| $12K-98.4% | $753K— | $0-100% | $1.09M— | $0-100% | ||
| $1.43M+457% | -$401K— | —— | -$1.4M-214% | $1.23M+305% | ||
| -$5.76M— | —— | -$1.29M— | —— | -$5.49M-146% | ||
| -$7.99M-647% | $1.46M— | —— | $3.28M+285% | $854K-72.0% | ||
| $166K+53.7% | $108K+221% | -$89K— | —— | $38K-49.5% | ||
| -$2K— | —— | $6K-33.3% | $9K— | $0— | ||
| $290K+1,426% | $19K— | —— | $1.03M+1,495% | -$74K+96.3% | ||
| $798K-12.9% | $916K-6.5% | $980K-16.0% | $1.17M+4.1% | $1.12M-47.2% | ||
| -$2.71M+21.5% | -$3.45M-1,236% | -$258K+94.3% | -$4.51M-667% | -$587K+79.2% | ||
| -$21K-110% | $206K+2,160% | -$10K+77.3% | -$44K+47.6% | -$84K+30.0% | ||
| -$467K-107% | $7.09M+121% | $3.2M-29.8% | $4.56M+18.0% | $3.86M+1,852% | ||
| $17K— | —— | —— | $5K-94.3% | $87K-73.1% | ||
| $21K+90.9% | $11K+10.0% | $10K0.0% | $10K-63.0% | $27K+58.8% | ||
| $0— | —— | —— | $34K-40.4% | $57K-44.7% | ||
| $0— | $0— | $0— | $0— | $0-100% | ||
| $2.69M+7.6% | $2.5M+400% | $500K-88.9% | $4.5M+800% | $500K-80.0% | ||
| $1.83M-6.7% | $1.96M+0.2% | $1.96M+31.5% | $1.49M-4.5% | $1.56M-47.0% | ||
| $1.46M-84.9% | $9.65M+208% | $3.13M-26.6% | $4.26M+523% | -$1.01M— | ||
| $396K-95.4% | $8.57M+318% | $2.05M-35.7% | $3.19M+252% | -$2.1M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is OptimizeRx's revenue?
- OptimizeRx (OPRX) generated $107.3M in revenue over the trailing twelve months, up 39.8% year over year.
- Is OptimizeRx profitable?
- OptimizeRx reported $6.8M in net income over the trailing twelve months, a 6.4% net margin.
- What are OptimizeRx's profit margins?
- Gross margin is 70.0% and operating margin is 13.2%, with a 6.4% net margin.
- What is OptimizeRx's earnings per share?
- OptimizeRx's diluted EPS over the trailing twelve months is $0.35.
- Where does OptimizeRx's income statement data come from?
- Every line is extracted from OptimizeRx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
